Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boneu

Showing results (21-30 of 233) with videos related to

Pageof 24
Sort By:
Presse Medicale (Paris, France : 1983)|February 7, 1987
[The other heparin cofactor]P Sie, B Boneu
Thrombosis and Haemostasis|December 1, 1996
Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patientsB Boneu, G Destelle
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Genetic predisposition to arterial and venous thrombosis]Y Cadroy, B Boneu
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics]B Boneu, P Léger
Transfusion Medicine Reviews|December 1, 1987
The role of the hematocrit in bleedingB Boneu, F Fernandez
Seminars in Thrombosis and Hemostasis|October 23, 2001
How and when to monitor a patient treated with low molecular weight heparinB Boneu, P de Moerloose
Bailliere'S Clinical Haematology|July 1, 1990
Pharmacokinetics of heparin and low molecular weight heparinB Boneu, C Caranobe, P Sie
La Nouvelle Presse Medicale|June 7, 1980
[Acquired deficiency of factor XII and antithrombin III (AT III) in nephroses of children. Preliminary results]F Bouissou, P Barthe, B Boneu
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Royat Study GroupB Boneu, P Leger, C Arnaud
Archives Francaises De Pediatrie|March 1, 1980
[Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)]F Bouissou, P Barthe, B Boneu
Pageof 24

Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
Presse Medicale (Paris, France : 1983)|February 7, 1987
[The other heparin cofactor]P Sie, B Boneu
Thrombosis and Haemostasis|December 1, 1996
Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patientsB Boneu, G Destelle
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Genetic predisposition to arterial and venous thrombosis]Y Cadroy, B Boneu
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics]B Boneu, P Léger
Transfusion Medicine Reviews|December 1, 1987
The role of the hematocrit in bleedingB Boneu, F Fernandez
Seminars in Thrombosis and Hemostasis|October 23, 2001
How and when to monitor a patient treated with low molecular weight heparinB Boneu, P de Moerloose
Bailliere'S Clinical Haematology|July 1, 1990
Pharmacokinetics of heparin and low molecular weight heparinB Boneu, C Caranobe, P Sie
La Nouvelle Presse Medicale|June 7, 1980
[Acquired deficiency of factor XII and antithrombin III (AT III) in nephroses of children. Preliminary results]F Bouissou, P Barthe, B Boneu
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Royat Study GroupB Boneu, P Leger, C Arnaud
Archives Francaises De Pediatrie|March 1, 1980
[Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)]F Bouissou, P Barthe, B Boneu
Pageof 24